Study: Drug Preserves Fertility in Younger Women With Cancer

A new treatment approach may help thousands of women with early-stage breast cancer avoid premature menopause and preserve their ability to have children, U.S. researchers said. A study, presented at the annual meeting of American Society of Clinical Oncology (ASCO) in Chicago, showed that women who received AstraZeneca PLC's drug goserelin along with chemotherapy were 64 percent less likely to develop premature menopause than women who had chemotherapy alone. They were also more...

© La Voix de l'Amérique - dimanche 1^er juin 2014